Analysis | Metabolite Name | Measured Value | Units | Sex | Severity_Scale | Race | Ethnicity | hasSmokingBeforeCOVID-19 | Time |
---|---|---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.697778155 | log transformed data | Male | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.687873081 | log transformed data | Male | 2 | White | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.681139756 | log transformed data | Female | 2 | White | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.667708081 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.660918505 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.657116811 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.642536876 | log transformed data | Female | 1 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.635558598 | log transformed data | Female | 1 | Other | Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.630444056 | log transformed data | Male | 3 | Other | Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.626862457 | log transformed data | Male | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.623175588 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.621895436 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.613823619 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.606940196 | log transformed data | Female | 1 | Other | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.604690459 | log transformed data | Female | 2 | Other | Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.604216838 | log transformed data | Female | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.590647692 | log transformed data | Male | 2 | Other | Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.58117755 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.580291448 | log transformed data | Female | 2 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.569676405 | log transformed data | Male | 1 | Other | Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.560479089 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.554098231 | log transformed data | Female | 0 | Other | Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.552397334 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.55027572 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.546478893 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.545884724 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.545812569 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.545448559 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.540277961 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.534657025 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.534140986 | log transformed data | Female | 0 | Other | Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.533418822 | log transformed data | Female | 1 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.532063997 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.531069044 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.525921411 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.52554198 | log transformed data | Female | 2 | White | Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.523075916 | log transformed data | Female | 2 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.519767278 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.518485567 | log transformed data | Male | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.518043637 | log transformed data | Female | 1 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.512553338 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.509896269 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.502150921 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.501718988 | log transformed data | Male | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.500217855 | log transformed data | Male | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.496689493 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.495506865 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.493771017 | log transformed data | Female | 1 | White | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.486452096 | log transformed data | Female | 0 | White | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.486190472 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.483780051 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.483225499 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.482607843 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.481189169 | log transformed data | Male | 1 | Other | Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.474712654 | log transformed data | Female | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.47272366 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.467010831 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.464426814 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.464257322 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.462087524 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.461776582 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.461001114 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.460544238 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.460206058 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.457340544 | log transformed data | Male | 3 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.454312318 | log transformed data | Female | 1 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.454023337 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.451696719 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.447568487 | log transformed data | Female | 1 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.445214214 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.442970879 | log transformed data | Female | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.442951649 | log transformed data | Male | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.44178478 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.439931175 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.436097492 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.433535153 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.433086379 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.427282629 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.424465428 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.421518156 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.417724508 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.417705026 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.415839139 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.410404709 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.408154739 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.406495604 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.405374181 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.405203373 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.404807442 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.404266674 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.403945833 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.403728447 | log transformed data | Male | 1 | Other | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.403527354 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.402858675 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.400740562 | log transformed data | Female | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.399581219 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.394814029 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.394783178 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.393158776 | log transformed data | Female | 3 | White | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.392343385 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.38937199 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.389295756 | log transformed data | Female | 3 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.387338514 | log transformed data | Female | 3 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.386227663 | log transformed data | Female | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.382925174 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.381199227 | log transformed data | Female | 1 | Other | Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.376911988 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.375934919 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.375193195 | log transformed data | Male | 1 | Other | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.374137005 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.3715778 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.37006078 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.366807465 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.36609028 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.365683829 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.364300608 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.360277849 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.357611192 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.356890777 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.353499638 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.351086462 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.350873672 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.350405561 | log transformed data | Female | 1 | Other | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.350075356 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.34930105 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.347710941 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.341993374 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.339924745 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.337846572 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.337014753 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.335507795 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.330196845 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.329543713 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.323315363 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.32015523 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.320019644 | log transformed data | Male | 3 | Other | Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.319932837 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.31666007 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.315629731 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.31249036 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.312253197 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.311072393 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.310605118 | log transformed data | Male | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.306478326 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.305418062 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.299536953 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.295435232 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.29495062 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.294799984 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.294742159 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.293017215 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.292273812 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.289361411 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.28822269 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.280893251 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.277697369 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.276010091 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.275277338 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.273761655 | log transformed data | Male | 1 | Other | Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.27259129 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.272488109 | log transformed data | Male | 0 | Other | Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.271494273 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.271220707 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.268973147 | log transformed data | Female | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.265091622 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.264956013 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.263844373 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.262430386 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.262404599 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.261048927 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.259855454 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.258705388 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.257808871 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.256471938 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.255270285 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.252367073 | log transformed data | Male | 2 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.24997548 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.249384202 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.248798234 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.244202216 | log transformed data | Male | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.242375804 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.239021504 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.23724321 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.236793474 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.233390283 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.231782546 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.231415668 | log transformed data | Female | 1 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.229939254 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.226982137 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.225574092 | log transformed data | Female | 0 | White | Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.225000952 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.223923976 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.222635033 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.220522458 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.216403687 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.215739577 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.214779445 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.210930275 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.200425884 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | phenylacetylglutamine | -0.198134088 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
Return to search page